Cargando…
Preclinical testing of 5-amino-1-((1R,2S,3S,4R)-2,3-dihydroxy-4-methylcyclopentyl)-1H-imidazole-4-carboxamide: a potent protein kinase C-ι inhibitor as a potential prostate carcinoma therapeutic
Protein kinase C-iota (PKC-ι) is an oncogene overexpressed in many cancer cells including prostate, breast, ovarian, melanoma, and glioma. Previous in-vitro studies have shown that 5-amino-1-((1R,2S,3S,4R)-2,3-dihydroxy-4-methylcyclopentyl)-1H-imidazole-4-carboxamide (ICA-1s), a PKC-ι specific inhib...
Autores principales: | Apostolatos, André H., Apostolatos, Christopher A., Ratnayake, Wishrawana S., Neuger, Anthony, Sansil, Samer, Bourgeois, Marie, Acevedo-Duncan, Mildred |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6287896/ https://www.ncbi.nlm.nih.gov/pubmed/30204596 http://dx.doi.org/10.1097/CAD.0000000000000694 |
Ejemplares similares
-
Oncogenic PKC-ι activates Vimentin during epithelial-mesenchymal transition in melanoma; a study based on PKC-ι and PKC-ζ specific inhibitors
por: Ratnayake, Wishrawana S., et al.
Publicado: (2018) -
Inhibition of atypical protein kinase C-ι effectively reduces the malignancy of prostate cancer cells by downregulating the NF-κB signaling cascade
por: Apostolatos, André H., et al.
Publicado: (2018) -
Two novel atypical PKC inhibitors; ACPD and DNDA effectively mitigate cell proliferation and epithelial to mesenchymal transition of metastatic melanoma while inducing apoptosis
por: Ratnayake, Wishrawana S., et al.
Publicado: (2017) -
Atypical PKCs activate Vimentin to facilitate prostate cancer cell motility and invasion
por: Ratnayake, Wishrawana S., et al.
Publicado: (2021) -
Analysis of PKC-ζ protein levels in normal and malignant breast tissue subtypes
por: Smalley, Tracess, et al.
Publicado: (2019)